Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Other solid neoplasm 1

Conditions

Oligodendroglioma 1Neurofibromatosis 1 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Ipilimumab 36Lomustine 35Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Outcome Assessment, Health Care × CNS × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT05186870 2023-03-03

Reliability of Functional Outcome Measures in Neurofibromatosis 1: Test- Retest

Guy's and St Thomas' NHS Foundation Trust

Unknown
20 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡